Hyperphosphatemia and hypercalcemia are independently associated with an increased risk of cardiovascular calcification and mortality in patients on dialysis. Sevelamer hydrochloride has the ...
J Ren Nutr. St-Jules DE, Woolf K, Pompeii M, Kalantar-Zadeh K, Sevick MA. Dietary phosphorus restriction is recommended to help control hyperphosphatemia in hemodialysis patients, but many ...
hyperphosphatemia), and also potentially decrease the risk of morbidity and mortality from cardiovascular disease and stroke by improving blood pressure control and preventing repeated cardiac ...